Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F WIELAND

Showing results (201-210 of 269) with videos related to

Pageof 27
Sort By:
BMC Cancer|October 10, 2012
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancerWolfgang Otto, Peter C Rubenwolf, Maximilian Burger, et al.
The Journal of Urology|September 25, 2012
Histone methylation defines an epigenetic entity in penile squamous cell carcinomaSebastian Rogenhofer, Herdis Miersch, Friederike Göke, et al.
The Journal of Pathology|May 11, 2013
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patientsRobert Stoehr, Helge Taubert, Nadine T Gaisa, et al.
Science (New York, N.Y.)|July 11, 2015
VESICULAR TRANSPORT. A structure of the COPI coat and the role of coat proteins in membrane vesicle assemblyS O Dodonova, P Diestelkoetter-Bachert, A von Appen, et al.
BJU International|February 9, 2012
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Thomas Martini, et al.
Clinical Genitourinary Cancer|July 16, 2013
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patientsWolfgang Otto, Stefan Denzinger, Hans-Martin Fritsche, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Robust hepatitis C virus infection in vitroJin Zhong, Pablo Gastaminza, Guofeng Cheng, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 6, 2013
Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomyStephan Buse, Thomas Höfner, Stephan C Müller, et al.
Urologia Internationalis|June 12, 2013
Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomyA Aziz, M Gierth, H M Fritsche, et al.
Medical Oncology (Northwood, London, England)|May 25, 2011
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trialB Walter, I Schrettenbrunner, M Vogelhuber, et al.
Pageof 27

Showing results (201-210 of 269) with videos related to

Sort By:
Pageof 27
BMC Cancer|October 10, 2012
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancerWolfgang Otto, Peter C Rubenwolf, Maximilian Burger, et al.
The Journal of Urology|September 25, 2012
Histone methylation defines an epigenetic entity in penile squamous cell carcinomaSebastian Rogenhofer, Herdis Miersch, Friederike Göke, et al.
The Journal of Pathology|May 11, 2013
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patientsRobert Stoehr, Helge Taubert, Nadine T Gaisa, et al.
Science (New York, N.Y.)|July 11, 2015
VESICULAR TRANSPORT. A structure of the COPI coat and the role of coat proteins in membrane vesicle assemblyS O Dodonova, P Diestelkoetter-Bachert, A von Appen, et al.
BJU International|February 9, 2012
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Thomas Martini, et al.
Clinical Genitourinary Cancer|July 16, 2013
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patientsWolfgang Otto, Stefan Denzinger, Hans-Martin Fritsche, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Robust hepatitis C virus infection in vitroJin Zhong, Pablo Gastaminza, Guofeng Cheng, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 6, 2013
Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomyStephan Buse, Thomas Höfner, Stephan C Müller, et al.
Urologia Internationalis|June 12, 2013
Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomyA Aziz, M Gierth, H M Fritsche, et al.
Medical Oncology (Northwood, London, England)|May 25, 2011
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trialB Walter, I Schrettenbrunner, M Vogelhuber, et al.
Pageof 27